BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31115562)

  • 21. Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.
    Wang L; Wu L; Pang J
    Oncol Rep; 2020 Oct; 44(4):1550-1560. PubMed ID: 32945481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of microRNA‑939 suppresses the development of human non‑small cell lung cancer via the upregulation of tissue inhibitor of metalloproteinases 2.
    Chen A; Liu S; Lu X; Wei L; Chen Y
    Mol Med Rep; 2018 Dec; 18(6):4831-4838. PubMed ID: 30272338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
    Gao N; Wang FX; Wang G; Zhao QS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.
    Liu F; Song D; Wu Y; Liu X; Zhu J; Tang Y
    Thorac Cancer; 2017 Nov; 8(6):613-619. PubMed ID: 28842954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines.
    Zhu X; Tian G; Quan J; He P; Liu J
    Int J Mol Med; 2019 Aug; 44(2):643-651. PubMed ID: 31173161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF; Zhang JG; Guo TX; Pan XJ
    Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1.
    Luo J; Jin Y; Li M; Dong L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
    Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
    Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA‑375 regulates the cell survival and apoptosis of human non‑small cell carcinoma by targeting HER2.
    Cheng L; Zhan B; Luo P; Wang B
    Mol Med Rep; 2017 Mar; 15(3):1387-1392. PubMed ID: 28098887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
    Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
    Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-497 acts as a tumor suppressor in gastric cancer and is downregulated by DNA methylation.
    Liu J; Li Y; Zou Y; Zhang J; An J; Guo J; Ma M; Dai D
    Oncol Rep; 2017 Jul; 38(1):497-505. PubMed ID: 28586056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
    Ding X; Yang Y; Sun Y; Xu W; Su B; Zhou X
    Clin Transl Oncol; 2017 May; 19(5):546-552. PubMed ID: 27743168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.